Investor Relations

IR Home

Webcast ImageWebcast
Q1 2016 Vanda Pharmaceuticals Inc. Earnings Conference Call (Live)
05/04/16 at 4:30 p.m. ET
Q1 2016 Vanda Pharmaceuticals Inc. Earnings Conference Call
Wednesday, May 4, 2016 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Stock Chart
VNDA (Common)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Up 0.17 (1.87%)
Data as of 04/28/16 3:22 p.m. ET
Minimum 20 minute delay
Refresh quote
Corporate Profile

Vanda is developing important new medicines to improve the lives of patients. We use new technologies, including genetics and genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. We are working to advance the science of developing new medicines and to use novel approaches to deliver these new medicines to patients... More >>

April 2016?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
52 Week High
Formats:  Excel HTML Adobe PDF Word

Primary IR Contact

For members of the press or investor community who wish to obtain more information about Vanda, please contact
Jim Kelly
Senior Vice President and Chief Financial Officer
Vanda Pharmaceuticals, Inc.
(202) 734-3428

Recent News
Vanda Pharmaceuticals to Announce First Quarter 2016 Financial Results on May 4, 2016
Vanda Pharmaceuticals Reports Fourth Quarter 2015 and Full Year 2015 Financial Results
Vanda Pharmaceuticals to Participate in the Canaccord Genuity Rare Disease, Biopharma One-on-One Day
More >>
Upcoming Events
Q1 2016 Vanda Pharmaceuticals Inc. Earnings Conference Call
Wednesday, May 4, 2016 4:30 p.m. ET

More >>

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Home | About Vanda | Product Pipeline| Partnering | Investor Relations | News | Careers | Contact Us
Copyright © 2005-2007 Vanda Pharmaceuticals | Terms & Conditions | Privacy Policy